Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
about
Association between Parkinson's Disease and Helicobacter PyloriNovel aspects of glucocorticoid actionsNon-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serumBlood dendritic cell frequency declines in idiopathic Parkinson's disease and is associated with motor symptom severitySerum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study.Imaging changes associated with cognitive abnormalities in Parkinson's diseaseEffect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson's Disease.Combination therapies: The next logical Step for the treatment of synucleinopathies?Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study.Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.Disrupted Nodal and Hub Organization Account for Brain Network Abnormalities in Parkinson's Disease.The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity.Immune responses in Parkinson's disease: interplay between central and peripheral immune systems.Qigong Exercise May Reduce Serum TNF-α Levels and Improve Sleep in People with Parkinson's Disease: A Pilot Study.Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.Peripheral Neuropathy and Hindlimb Paralysis in a Mouse Model of Adipocyte-Specific Knockout of Lkb1.Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson's Disease.
P2860
Q26765136-DBF4C399-3CD6-4598-B4BE-E02D2A16E5AFQ34169672-A46951B6-33A5-46FC-B225-FD7AF65EDEEEQ34452085-5F69DCB1-DA8C-4C6C-928D-3ABBB95FC1B5Q34775683-F413C94B-ECAF-4670-ADA1-4A938261EDD2Q35027763-FD7DF44A-1668-432C-911E-FA30F913F651Q35797763-B9CE3999-0FA4-4FDA-BA53-96E2DC61B507Q35999154-EB5CF533-E1B5-4348-9478-AA732B560F63Q36563062-A464D9BE-A73D-4429-8FA3-862716416E9EQ36858244-FC0D05EA-3AF3-4962-895F-49F85840854FQ37345484-1514279F-B28A-4773-A61E-63297FDF6A5EQ37405048-ABAD3469-865E-4819-90A3-E8BC439CB63CQ38670012-C6033D3C-2FD9-4B66-ABFC-D868AD268746Q38951947-76097999-1F52-4D79-891B-3E7EF040B2F9Q40157769-B892914C-08D4-4010-A339-EFA88393EC35Q41262976-5352032E-0084-454C-9810-B22701939077Q41529537-F9368163-FED2-4234-9CB3-9EB6BA3BFA54Q42001519-06B2C06A-A136-449C-887E-187E5C8D520BQ42651355-E6A47698-BD76-4619-8FF4-903F5930CD1DQ48172426-67B68B54-F438-4ABF-A8C5-54C5386739A9
P2860
Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
@ast
Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
@en
type
label
Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
@ast
Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
@en
prefLabel
Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
@ast
Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
@en
P2860
P1476
Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
@en
P2093
Christopher J Barnum
P2860
P2888
P304
P356
10.1007/S11910-012-0283-6
P577
2012-08-01T00:00:00Z
P6179
1006000642